Molecular predictors and immunomodulatory role of dual checkpoint inhibitor blockade using ipilimumab/nivolumab in patients with extensive stage small cell lung cancer

被引：0
|
作者：
Chiang, Anne C.
Asghari, Hossein
Ashley, Kerryan
Gettinger, Scott N.
Goldberg, Sarah B.
Herbst, Roy S.
Wilson, Frederick Hugh
Newton, Benjamin Robert
Cohenuram, Michael Keith
Sabbath, Kert D.
Talsania, Ashita D.
Russo, Armand Vincent
Schultz, Eric
Skrzypczak, Stan
Kingsford, Carl
Schalper, Kurt A.
机构：
[1] Yale Univ, Sch Med, New Haven, CT USA
[2] Ocean Genom, Pittsburgh, PA USA
[3] Yale Univ, Dept Pathol, New Haven, CT USA
[4] Yale Sch Med, New Haven, CT USA
[5] Yale Canc Ctr, New Haven, CT USA
[6] Smilow Canc Hosp Yale New Haven, Yale Sch Medicinel, Yale Canc Ctr, New Haven, CT USA
[7] Yale Univ, New Haven, CT USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8597
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Assessing ctDNA using a Methylation-informed Molecular Response Algorithm in Extensive-Stage Small Cell Lung Cancer Patients
    Gheeya, J. S.
    Bucheit, L.
    Solomon, S. R.
    Yablonovitch, A.
    Pilcher, C.
    Presley, C. J.
    Bertino, E.
    Shields, P. G.
    He, K.
    Sukrithan, V.
    Konda, B.
    Verschraegen, C. F.
    Carbone, D.
    Otterson, G. A.
    Owen, D. H.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S356 - S356
  • [32] Nivolumab Plus Ipilimumab in Relapsed Stage III Non-Small Cell Lung Cancer After Durvalumab Following Chemoradiotherapy
    Tokito, T.
    Mouri, A.
    Watanabe, S.
    Nagai, Y.
    Imai, H.
    Yamaguchi, O.
    Saida, Y.
    Kobayashi, K.
    Kaira, K.
    Kagamu, H.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S589 - S589
  • [33] Febrile Neutropenia in a Patient with Non-Small Cell Lung Cancer Treated with the Immune-Checkpoint Inhibitor Nivolumab
    Hisamatsu, Yasushi
    Morinaga, Ryotaro
    Watanabe, Erina
    Ohtani, Satoshi
    Shirao, Kuniaki
    AMERICAN JOURNAL OF CASE REPORTS, 2020, 21
  • [34] Efficacy and safety of immune checkpoint inhibitors (ICIs) in extensive-stage small cell lung cancer (SCLC)
    Ma, Xiaoting
    Wang, Shan
    Zhang, Yujian
    Wei, Huamin
    Yu, Jing
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021, 147 (02) : 593 - 606
  • [35] Efficacy and safety of immune checkpoint inhibitors (ICIs) in extensive-stage small cell lung cancer (SCLC)
    Xiaoting Ma
    Shan Wang
    Yujian Zhang
    Huamin Wei
    Jing Yu
    Journal of Cancer Research and Clinical Oncology, 2021, 147 : 593 - 606
  • [36] Prophylactic cranial irradiation in patients with extensive-stage small cell lung cancer
    Aizer, Ayal A.
    Mak, Raymond
    Alexander, Brian M.
    NEURO-ONCOLOGY, 2017, 19 (08) : 1015 - 1016
  • [37] A Phase 2 Study of Prexasertib in Patients with Extensive Stage Small Cell Lung Cancer
    Byers, Lauren Averett
    Golden, Lisa
    Zhang, Wei
    Lin, Aimee Bence
    Forster, Martin
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1088 - S1089
  • [38] Current status and future perspectives of immune checkpoint inhibitors in extensive-stage small cell lung cancer
    Liu, Xingyu
    Xing, Huifang
    Liu, Baoxing
    AMERICAN JOURNAL OF CANCER RESEARCH, 2022, 12 (06): : 2447 - 2464
  • [39] A Phase 2 Trial of Nivolumab and Temozolomide in Extensive Stage Small Cell Lung Cancer: Interim Efficacy Analysis.
    Owen, D.
    Wei, L.
    Pilcher, C.
    Patel, S.
    Konda, B.
    Shah, M.
    Ferguson, S.
    Benner, B.
    Norman, R.
    Carson, W.
    Smith, M.
    Vogt, S. Mori
    Verschraegen, C.
    He, K.
    Bertino, E.
    Presley, C.
    Shields, P.
    Carbone, D.
    Otterson, G.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S647 - S647
  • [40] Role of radiation in extensive stage small cell lung cancer: a National Cancer Database registry analysis
    Sheikh, Saad
    Dey, Asoke
    Datta, Sujay
    Podder, Tarun K.
    Jindal, Charulata
    Dowlati, Afshin
    Efird, Jimmy Tf
    Machtay, Mitchell
    Biswas, Tithi
    FUTURE ONCOLOGY, 2021, 17 (21) : 2713 - 2724
12345